STOP Regulators are reviewing the safety of the Alzheimer 's disease drug MISC after data from NUMBER clinical trials indicated that people taking the drug had a much higher death rate than those taking a placebo STOP  The review was announced DATE by ORGANIZATION which said it was in discussions with the ORGANIZATION and regulators in LOCATION and LOCATION STOP 